CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.104
EU - Europa 3.677
AS - Asia 3.557
SA - Sud America 334
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 12.710
Nazione #
US - Stati Uniti d'America 5.024
SG - Singapore 1.383
CN - Cina 1.145
UA - Ucraina 811
TR - Turchia 640
IE - Irlanda 605
GB - Regno Unito 559
SE - Svezia 505
FR - Francia 334
DE - Germania 312
BR - Brasile 286
FI - Finlandia 200
IN - India 180
IT - Italia 135
RU - Federazione Russa 129
VN - Vietnam 73
CA - Canada 43
MX - Messico 27
AR - Argentina 23
PL - Polonia 22
KR - Corea 21
HK - Hong Kong 17
BD - Bangladesh 16
CZ - Repubblica Ceca 15
ZA - Sudafrica 13
ES - Italia 12
JP - Giappone 12
NL - Olanda 10
EU - Europa 9
ID - Indonesia 9
IQ - Iraq 9
AT - Austria 8
EC - Ecuador 8
IL - Israele 7
IR - Iran 6
SA - Arabia Saudita 6
LT - Lituania 5
PK - Pakistan 5
VE - Venezuela 5
CO - Colombia 4
JO - Giordania 4
MA - Marocco 4
TW - Taiwan 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
HN - Honduras 3
QA - Qatar 3
RO - Romania 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
CL - Cile 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
PY - Paraguay 2
AM - Armenia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
IM - Isola di Man 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 12.710
Città #
Singapore 1.067
Jacksonville 857
Chandler 740
Dublin 602
Southend 454
Princeton 314
Izmir 311
Beijing 308
Ashburn 244
Dallas 233
Nanjing 202
Wilmington 184
Santa Clara 170
Los Angeles 151
Cambridge 143
Dearborn 132
Tongling 107
Munich 83
Buffalo 79
The Dalles 76
New York 75
Nanchang 74
Woodbridge 68
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
Council Bluffs 39
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 33
Ho Chi Minh City 31
São Paulo 31
Helsinki 30
Changsha 28
Jiaxing 28
Turku 28
Houston 25
Moscow 24
Norwalk 24
Brooklyn 22
Seoul 20
Chennai 19
Montreal 18
Hangzhou 17
Hong Kong 17
Redondo Beach 17
Warsaw 17
Hefei 16
Augusta 15
Orange 15
Chieti 14
Falls Church 14
Denver 13
Hanoi 13
Jinan 13
San Mateo 13
Seattle 12
Tokyo 12
Atlanta 11
Chicago 11
Poplar 11
Boston 10
Brno 10
Frankfurt am Main 10
Johannesburg 10
Toronto 10
Mexico City 9
Stockholm 9
Changchun 8
Lanzhou 8
Phoenix 8
Zhengzhou 8
Auburn Hills 7
Brasília 7
Leawood 7
Orem 7
Rio de Janeiro 7
Amsterdam 6
Ankara 6
Belo Horizonte 6
Roubaix 6
San Francisco 6
Charlotte 5
London 5
Manchester 5
Mumbai 5
Ningbo 5
Pune 5
Querétaro 5
Taiyuan 5
Guayaquil 4
Hackney 4
Monte Grande 4
Mountain View 4
Olomouc 4
Ottawa 4
Perugia 4
Totale 7.896
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 157
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 150
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 136
Amylin inhibits hypothalamic dopamine release. 135
Determinants of platelet activation in hypertensives with microalbuminuria. 135
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 133
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 130
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 129
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 128
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 126
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 125
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 124
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 124
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 120
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 120
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 118
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 118
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 118
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 115
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 115
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 115
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 114
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 114
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 113
Insulin resistance as a determinant of platelet activation in obese women. 112
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 112
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 108
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 108
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 107
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 106
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 106
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 105
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 105
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 104
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 103
Determinants of platelet activation in hypertensives with microalbuminuria. 102
Soluble RAGE in type 2 diabetes: association with oxidative stress. 101
Tachykinin-eicosanoid crosstalk in airway inflammation 100
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 100
Determinants of platelet activation in Alzheimer's disease 100
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 99
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 99
Effects of anthracyclines on hypothalamic dopamine release. 98
Association between PAI-1 and Oxidative Stress in Android Obesity 98
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 98
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 98
Increased exhaled 8-isoprostane in childhood asthma. 97
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 97
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 97
Role of Platelet Activation in Dementia 96
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 96
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 96
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 96
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 96
Increased thromboxane biosynthesis in essential thrombocythemia 95
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 95
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 95
Measurement of 8-isoprostane in exhaled breath condensate. 95
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 93
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 92
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 92
Insulin resistance as a determinant of platelet activation in obese women 92
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 91
Drugs, prostaglandins, and renal function. 90
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 90
Validation of leukotriene B4 measurements in exhaled breath condensate. 89
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 89
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 89
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 88
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 88
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 87
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 87
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 87
Determinants of Platelet Activation in Heart Failure. 87
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 87
Oxidative stress and platelet activation in children and adolescents with type 1 diabetes: role of interleukin-6 86
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 86
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 85
Platelet activation in obese women: role of inflammation and oxidant stress. 85
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 85
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 84
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 83
Soluble CD40L as an indicator of platelet Activation in Heart Failure 83
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 83
Enhanced lipid peroxidation and platelet activation in the early stages of type 1 diabetes mellitus. Role of Interleukin-6 and disease duration. 83
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 83
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 82
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 82
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 82
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 81
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 81
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 80
Tachykinin-eicosanoid crosstalk in airway inflammation 80
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 79
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 79
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 79
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 78
Determinants of Platelet Activation in Heart Failure. 78
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 77
Totale 10.018
Categoria #
all - tutte 50.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 198 2 7 85 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20262.037 429 255 407 464 423 59 0 0 0 0 0 0
Totale 12.958